Type 2 Diabetes Medicines Exporter India to USA | City Drug House
City Drug House is a trusted exporter of Hepaglide 0.25 mg from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Hepaglide 0.25 mg injection is a brand of semaglutide, a GLP-1 receptor agonist designed for once-weekly subcutaneous administration to treat type 2 diabetes. It works by mimicking natural hormones to increase insulin secretion, reduce liver glucose production, and slow gastric emptying, thereby improving glycemic control.
Key Pharmacological Aspects of Hepaglide 0.25 mg:
Mechanism of Action: As a GLP-1 (Glucagon-like Peptide-1) receptor agonist, it enhances glucose-dependent insulin secretion, lowers glucagon secretion when blood sugar is high, and slows gastric emptying to improve blood sugar control.
Indication: Used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Dosage & Administration: The 0.25 mg dose is used for initiation of treatment to allow the body to adjust. It is injected once-weekly into the abdomen, thigh, or upper arm.
Pharmacokinetics: Due to its once-weekly, subcutaneous administration, it provides sustained therapeutic levels.
Common Side Effects: The most frequent side effects are gastrointestinal, including nausea, vomiting, diarrhea, stomach pain, and constipation.
Warnings: It should be used with caution and under medical supervision, particularly to monitor for signs of pancreatitis or allergic reactions.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted exporter of Hepaglide 0.25 mg from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Hepaglide 0.25 mg injection is a brand of semaglutide, a GLP-1 receptor agonist designed for once-weekly subcutaneous administration to treat type 2 diabetes. It works by mimicking natural hormones to increase insulin secretion, reduce liver glucose production, and slow gastric emptying, thereby improving glycemic control.
Key Pharmacological Aspects of Hepaglide 0.25 mg:
Mechanism of Action: As a GLP-1 (Glucagon-like Peptide-1) receptor agonist, it enhances glucose-dependent insulin secretion, lowers glucagon secretion when blood sugar is high, and slows gastric emptying to improve blood sugar control.
Indication: Used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Dosage & Administration: The 0.25 mg dose is used for initiation of treatment to allow the body to adjust. It is injected once-weekly into the abdomen, thigh, or upper arm.
Pharmacokinetics: Due to its once-weekly, subcutaneous administration, it provides sustained therapeutic levels.
Common Side Effects: The most frequent side effects are gastrointestinal, including nausea, vomiting, diarrhea, stomach pain, and constipation.
Warnings: It should be used with caution and under medical supervision, particularly to monitor for signs of pancreatitis or allergic reactions.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
